Bulgaria vs Faroe Islands: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Bulgaria
0.0%
in 2024
Faroe Islands
0.0%
in 2024
Bulgaria rank
143rd
Faroe Islands rank
143rd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Bulgaria
- Faroe Islands
How they compare
Bulgaria currently reports 0.0% against 0.0% in Faroe Islands, a difference of 0.0%.
Across all 10 years both countries report, Faroe Islands has been ahead every year.
Bulgaria ranks 143rd and Faroe Islands ranks 143rd of 215 countries.
Faroe Islands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bulgaria | Faroe Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.1% | 0.1% | Faroe Islands |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Bulgaria or Faroe Islands?
- Bulgaria, at 0.0% against 0.0% in Faroe Islands as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Bulgaria and Faroe Islands?
- 0.0%, with Bulgaria ahead.
- How many years of comparable data are there for Bulgaria and Faroe Islands?
- 10 years are reported by both, from 2015 to 2024.
- How do Bulgaria and Faroe Islands rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Bulgaria ranks 143rd and Faroe Islands ranks 143rd of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.